Reckitt, Abbott surge after winning an NEC case By Investing.com

Published on 1 Nov 2024 on Investing.com

The verdict dismissed claims that the companies had failed to adequately warn of risks associated...

Read the rest of the article

Start tracking your investments with Statfolio

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. ...

Insider Monkey · via Yahoo Finance 7 Nov 2024

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 5 Nov 2024

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that...

CNBC 2 Nov 2024

The verdict dismissed claims that the companies had failed to adequately warn of risks associated...

Investing.com 1 Nov 2024

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London...

Investopedia · via Yahoo Finance 1 Nov 2024

Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a...

CNBC 1 Nov 2024

A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt unit Mead Johnson are not...

Reuters · via Yahoo Finance 1 Nov 2024

Abbott Laboratories is the #1 healthcare stock to own over the long term, providing a market-beat...

Investing.com 31 Oct 2024

Instead of using future free cash flow as in the traditional DCF model, the GuruFocus DCF calcula...

GuruFocus.com · via Yahoo Finance 30 Oct 2024

David Jagielski (Abbott Laboratories): When you're looking for good dividend growth stocks to hol...

The Motley Fool 26 Oct 2024